Novocure
Elisabetta Tortorella, PhD, currently serves as a Clinical Scientist in Clinical Development at Novocure, focusing on study protocol development, medical data review, and fostering relationships with clinical investigators. Prior to this role, Elisabetta completed a PhD in Molecular Medicine at Sapienza Università di Roma, where research included studying biomarkers and therapies for advanced prostate cancer. Additional experience includes positions as a Clinical Research Associate at IQVIA and OPIS s.r.l., research roles at KU Leuven and University of Rome Tor Vergata, and involvement in clinical study management at Policlinico Umberto I. Educational credentials encompass a PharmD and master's degree in clinical research, complemented by an Erasmus+ project in Spain.
This person is not in any offices
Novocure
3 followers
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.